Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 5 - Drugs for disorders of the endocrine system
Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
11/2007
11/07/2007CN100347293C Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
11/07/2007CN100347152C Benzamide or phenylacetamide derivatives useful as thyroid receptor ligands
11/07/2007CN100346823C Enamel matrix protein compositions for modulating immune response
11/07/2007CN100346772C Devices for delivery of drugs having antiprogestinic properties
11/06/2007US7291637 4,7-Methano--, ethano-, oxy- or thio- indazol-3-ones or benzisothiazol-3-ones in which the S is mono- or dioxygenated, e.g., 3a,4,7,7a-tetrahydro-4,7-methano-1,2-benzisothiazol-3(2H)-one-1,1-dioxide; treatment of diseases such as cancer and immune disorders
11/06/2007US7291635 Protein tyrosine phosphatase 1B inhibitors alone or incombination with other antidiabetic, antilipemic, anticholesterol or hypotensive agents
11/06/2007US7291633 nicotinic alpha 7 receptor and 5-HT3 or 5-HT6 receptor; control of cholinergic and dopaminergic neurotransmission; disorders of the central nervous system and serotonergic hyperactivity; psychiatric and neurodegenerativce disorders; antiemetics during chemotherapy
11/06/2007US7291609 Specific glucocorticosteroid compound having anti-inflammatory activity
11/06/2007US7291608 Anti-inflammatory 17.β.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.α
11/06/2007US7291593 Administering follicle stimulating hormone (FSH) at an initial dose in the range of from 100 to 600 IU followed by a second dose at least 3 days later in the stimulation phase for therapy of infertility in women
11/06/2007US7291347 Solubility, permeability, and bioavailability; oral dosage
11/06/2007US7291330 MD-1 inhibitors as immune suppressants
11/01/2007WO2007122165A1 Novel compounds
11/01/2007WO2007103694A3 Triazine 11-beta hydroxysteroid dehydrogenase type i inhibitors
11/01/2007WO2007098382A3 17-phosphorous steroid derivatives useful as progesterone receptor modulators
11/01/2007WO2007066192A3 Method for weight reduction
11/01/2007WO2007028135A3 Imidazopyridine compounds
11/01/2007US20070254886 N-[5-bromo-3-({3-[2-(dimethylamino)ethoxy]-4-methoxybenzyl}oxy)pyridin-2-yl]-4-methylbenzenesulfonamide, used for prevention and/or treatment of infections, inflammatory and/or allergic diseases
11/01/2007US20070254875 Androgen Receptor Modulator Compounds and Methods
11/01/2007US20070253934 New strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it
11/01/2007CA2800389A1 Glp-1 compounds
11/01/2007CA2649509A1 Novel compounds
10/2007
10/31/2007EP1849801A1 Tyrosine-based motif and clostridial neurotoxins
10/31/2007EP1849795A1 1-substituted-7-( -d-glycopyranosyloxy)(aza)indole compound and pharmaceutical containing the same
10/31/2007EP1849469A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
10/31/2007EP1848416A2 Methods and materials with trans-clomiphene for the treatment of male infertility
10/31/2007EP1531807A4 Bazedoxifene treatment regimens
10/31/2007EP1496896A4 Inhibitors of akt activity
10/31/2007EP1289993B1 Caspase inhibitors and uses thereof
10/31/2007EP1012189B1 Treatment of obesity
10/31/2007CN200966670Y Intra-uterine contraceptive device
10/31/2007CN101065148A Conjugated complement cascade inhibitors
10/31/2007CN101062117A Capsule for eliminating phlegm and relaxing heart
10/31/2007CN100345863C Estrieno[3,2-b]/[3,4-c]pyrrole derivatives useful as modulators of the estrogen receptors
10/31/2007CN100345834C 异羟肟酸衍生物 Hydroxamic acid derivatives
10/31/2007CN100345829C Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
10/31/2007CN100345535C The Controlled release preparation of insulin and its method
10/30/2007US7288571 Thyroid receptor ligands and method II
10/30/2007US7288536 For therapy of skin diseases such as eczema, psoriasis, allergic dermatitis neurodermatitis, pruritis and hypersensitivity reactions; inflammatory conditions of the nose, throat or lungs such as asthma (including allergen-induced asthmatic reactions), rhinitis (including hayfever), nasal polyps
10/30/2007US7288390 Anti-dual integrin antibodies, compositions, methods and uses
10/30/2007CA2264002C Naphthyl compounds, intermediates, compositions, and methods of use
10/25/2007WO2007119684A1 Spraying agent
10/25/2007WO2007119623A1 Novel use of g-protein-conjugated receptor and ligand thereof
10/25/2007WO2007118717A2 METHOD FOR PREPARING 4-[17β-METHOXY-17α-METHOXYMETHYL-3-OXOESTRA-4,9-DIEN-11β-YL]BENZALDEHYDE (E)-OXIME (ASOPRISNIL)
10/25/2007WO2007118711A1 17α-SUBSTITUTED 4-(3-OXOESTRA-4,9-DIEN-11β-YL)-BENZOIC ACID, ITS DERIVATIVES AND PROCESS FOR ITS PRODUCTION
10/25/2007US20070249703 (Hydroxyphenyl)-1H-Indole-3-Carbaldehyde Oxime Derivatives As Estrogenic Agents
10/25/2007US20070249698 Diarylimidazoles, substituted with another aromatic ring and one or more carboxylic acids, esters or amides, e.g., 3-[5-Benzo[1,3]dioxol-5-yl-4-(2,5-dichloro-phenyl)-1H-imidazol-2-yl]-2-(3-chloro-phenyl)-acrylic acid; treatment of conditions such as pain, drug dependence, and psychological disorders
10/25/2007US20070249697 3-[3-(3-chloro-4-cyanophenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl]propane-1-sulfonic acid amide; anti-androgen activity; treatment of prostate cancer, benign prostatic hypertrophy, male pattern baldness, sexual precociousness, common acne, seborrhea
10/25/2007US20070249661 Compounds for inflammation and immune-related uses
10/25/2007US20070249659 melanin concentrating hormone receptor antagonist; preventing or treating vascular system diseases, nervous system disorders, metabolic disorders, urogenital diseases, respiratory diseases disorders; N-(2-ethyl-3-methylimidazo[1,2-a]pyridin-6-yl)-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide
10/25/2007US20070249630 Phenethanolamine derivatives for treatment of respiratory diseases
10/25/2007US20070249605 such as methyl 2-(4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetate
10/25/2007US20070248663 Utilization of Dialkylfumerates
10/25/2007US20070248662 Immunosuppressants; for use in transplantation medicine or treatment of autoimmune diseases such as polyarthritis but not psoriatitc arthritis; micro-tablets, pellets
10/25/2007US20070248597 Methods of decreasing vascular calcification using IL-1 inhibitors
10/25/2007US20070248590 Modulators of CDC2-like kinases (CLKS) and methods of use thereof
10/25/2007US20070248585 Methods of regulating renalase (Monoamime Oxidase C)
10/25/2007CA2648537A1 Method for preparing 4-[17.beta.-methoxy-17.alpha.-methoxymethyl-3-oxoestra-4,9-dien-11.beta.-yl]benzaldehyde (e)-oxime (asoprisnil)
10/24/2007EP1847550A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
10/24/2007EP1847548A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
10/24/2007EP1847541A1 Fused pyrimidine derivative and uses thereof
10/24/2007EP1847266A1 Metabolic syndrome-improving agent and medicine, supplement, functional food and food additive containing the same
10/24/2007EP1847244A1 Metabolic syndrome-improving agent and medicine, supplement, functional food and food additive containing the same
10/24/2007EP1846434A1 NANDROLONE 17ß-CARBONATES
10/24/2007EP1846105A2 Use of adrenergic alpha2b antagonists for the treatment of vasomotor symptoms
10/24/2007EP1606307B1 Estrieno[3,2-b]/[3,4-c]pyrrole derivatives useful as modulators of the estrogen receptors
10/24/2007EP1207860B1 Controlled release pellet formulation
10/24/2007CN101060838A Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators
10/24/2007CN101060830A Combination of a NMDA receptor antagonist and an anti-depressive drug mao-inhibitor or a gadph-inhibitor for the treatment of psychiatric conditions
10/24/2007CN101057930A Medicine for treating thyroidism
10/24/2007CN100344629C Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors
10/24/2007CN100344610C Aryl-carbaldehyde oxime derivatives and their use as estrogenic agents
10/24/2007CN100344362C Fine particles, method and device for preparation thereof, and agent for parenteral injection and method for production thereof
10/24/2007CN100344278C Lasofoxifene tablet and its coating
10/23/2007US7285683 Bicyclic and tricyclic cannabinoids
10/23/2007US7285680 β-alanine derivatives and the use thereof
10/23/2007US7285662 Therapeutic heterocyclic compounds
10/23/2007US7285661 Starch derivatives, starch active substance conjugates, method for the production thereof and their use as medicaments
10/23/2007US7285635 Reducing the antigenicity of a proteinaceous compound while maintaining the compound's biological activity
10/23/2007US7285525 Suppression of immune response via inhibition of cathepsin S
10/23/2007CA2478971C Androstenones
10/23/2007CA2449679C Androstenones
10/23/2007CA2280041C Antigestagenic steroids with a fluorinated 17.alpha.-alkyl chain
10/18/2007WO2007118198A2 2-METHYLENE-1α,25-DIHYDROXY-19,21-DINORVITAMIN D3 ANALOGS AND USES THEREOF
10/18/2007WO2007117438A2 Methods for the production of functional protein from dna having a nonsense mutation and the treatment of disorders associated therewith
10/18/2007WO2007116099A1 Imidazo compounds
10/18/2007WO2007116098A1 Spiro-imidazo compounds
10/18/2007US20070244161 Novel mercaptophenyl naphthyl methane compounds and synthesis thereof
10/18/2007US20070244063 Inducing angiogenesis comprising contacting endothelial cells expressing Bv8 receptor with a polypeptide comprising the amino acid sequence of SEQ ID NO:2; using Bv8 polypeptides to induce endothelial cell proliferation and to enhance endothelial cell survival; screening for Bv8 modulators
10/18/2007US20070244049 Compositions and methods for enhanced mucosal delivery of parathyroid hormone
10/18/2007US20070243226 Growth factor complex
10/18/2007DE102006018869A1 17alpha-substituierte 4-(3-Oxoestra-4,9-dien-11beta-yl)-benzoesäure, deren Derivate und Verfahren zu ihrer Herstellung 17alpha-substituted 4- (3-oxoestra-4,9-dien-11beta-yl) benzoic acid, their derivatives and process for their preparation
10/18/2007DE102006017827A1 Neue kristalline Verbindungen New crystalline compounds
10/18/2007CA2649213A1 Imidazo compounds
10/18/2007CA2649210A1 Spiro-imidazo compounds
10/18/2007CA2648324A1 2-methylene-1.alpha.,25-dihydroxy-19,21-dinorvitamin d3 analogs and uses thereof
10/18/2007CA2647903A1 Methods for the production of functional protein from dna having a nonsense mutation and the treatment of disorders associated therewith
10/17/2007EP1844780A2 Derivatives of aryl-quinazoline/aryl-2-amino-phenyl methanone which promote the release of parathyroid hormone
10/17/2007EP1844774A2 A pharmaceutical composition for angiotensin II-mediated diseases
10/17/2007EP1844770A1 Tablets containing ornithine hydrochloride
1 ... 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 ... 290